Abstract
Clinical OMICsVol. 1, No. 4 CASE STUDYDetection and Interpretation of Rare Sub-Clonal Cancer Driver MutationsAnika Jöcker, Rupert Yip, and Salim EssakaliAnika JöckerANIKA JÖCKER, is Global Product Manager, Qiagen Aarhus. (E-mail Address: ajoecker@clcbio.com)Search for more papers by this author, Rupert YipRUPERT YIP, is Director, Product Management at QIAGEN Silicon Valley. (E-mail Address: Rupert.Yip@qiagen.com)Search for more papers by this author, and Salim EssakaliSALIM ESSAKALI, is Senior Global Product Manager at QIAGEN. (E-mail Address: Salim.Essakali@qiagen.com)Search for more papers by this authorPublished Online:15 Oct 2015https://doi.org/10.1089/clinomi.01.04.08AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 1Issue 4May 2014 InformationCopyright © GEN PublishingTo cite this article:Anika Jöcker, Rupert Yip, and Salim Essakali.Detection and Interpretation of Rare Sub-Clonal Cancer Driver Mutations.Clinical OMICs.May 2014.23-24.http://doi.org/10.1089/clinomi.01.04.08Published in Volume: 1 Issue 4: October 15, 2015PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
